Skip to main content
Search hero banner

Search results

Showing 581 - 600 of 651 results

Helium polariser

Helium 3 Polariser

This state-of-the-art metastable-exchange optical-pumping helium-3 polarising system enables polarisation-analysis experiments on five of our existing instruments.

Inaugural particle therapy study tour to Japan

Australian researchers and clinicians have recently returned from Japan where they investigated the use of advanced radiation therapy for cancer using heavy ions at particle therapy facilities on a study tour .

Chronic Kidney disease of unknown origin

Chronic kidney disease of unknown origin

In 2017, ANSTO's CEO signed a Memorandum of Understanding with Sri Lanka to work together to investigate the epidemiology of Chronic Kidney Disease of unknown origin (CKDu).

Dr Kathleen Riches
Quality and Risk Manager

Kathleen manages the quality and document management systems, and oversees procedures for inspection, testing, and calibration of equipment and systems, to support the accelerator operations and beam lines.

Ms Karen Wilde
NDF User Program Manager & Protein Labelling Specialist, National Deuteration Facility
Role at ANSTO
After your experiment clayton

After your experiment

Following your experiment at the Australian Synchrotron there are certain tasks that users can complete including a user feedback survey and claiming reimbursement for travel expenses.

Pagination